top of page

Neurotech Pharmaceuticals, Inc. Granted Fast Track

Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2.


View PDF Version




MacTel_FastTrack
.pdf
Download PDF • 106KB


105 views
bottom of page